PSMB8 and infection: Although we did not observe reduced frequency of intestinal CD8+ T cells in AOM/DSS treated mice lacking LMP7, a treatment with LMP7 inhibitor might have some undesired side effects such as increased susceptibility to certain infections and altered antigen processing of tumor neoantigens.